Article Sidebar
Views pdf: 124
PATTERN OF ADHERENCE TO GUIDELINE-DIRECTED MEDICAL THERAPY AMONG ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION AT FRIENSHIP HOSPITAL
Main Article Content
Abstract
Objective: To analyze the characteristics of outpatient prescription of Guideline-directed medical therapy (GDMT) for elderly heart failure patients with reduced ejection fraction managed at Friendship Hospital. Methods: A retrospective cross-sectional study examining the characteristics of guideline-directed medical therapy (GDMT) prescriptions during three consecutive follow-up visits for patients diagnosed with heart failure with reduced ejection fraction. Results: In a cohort of 98 patients, the initial prescription rates for ACE-I/ARB/ARNI, BB, MRA, and SGLT2i were 76.5%, 16.3%, 43.9%, and 13.3%, respectively. These figures did not exhibit an increase in subsequent follow-up visits. The percentage of patients receiving the target doses for the four drug groups was 0.0%, 7.1%, 26.8%, and 100.0%, respectively. Conclusion: The prescription rate and dosage of GDMT medications in elderly heart failure patients with reduced ejection fraction remain comparatively. Additional qualitative research is required to comprehend physicians' perspectives on prescribing GDMT medications for this population, with the aim of enhancing the quality of prescribing for elderly heart failure patients.
Article Details
Keywords
heart failure, heart failure with reduced ejection fraction, GDMT, elderly patient
References
2. Nguyễn Hữu Duy, Nguyễn Thị Liên Hương, et al. (2021), "Phân tích thực trạng kê đơn dựa trên bằng chứng ở các bệnh nhân suy tim tâm thu trong chương trình quản lý ngoại trú tại bệnh viện Tim Hà Nội", Tạp chí Y học Việt Nam, 509(1), pp.
3. Groenewegen A., Rutten F. H., et al. (2020), "Epidemiology of heart failure", Eur J Heart Fail, 22(8), pp. 1342-1356.
4. Jones N. R., Roalfe A. K., et al. (2019), "Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis", Eur J Heart Fail, 21(11), pp. 1306-1325.
5. Lainscak M., Milinkovic I., et al. (2020), "Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry", Eur J Heart Fail, 22(1), pp. 92-102.
6. McDonagh Theresa A, Metra Marco, et al. (2021), "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC", European Heart Journal, 42(36), pp. 3599-3726.
7. Sauer A. J., Cole R., et al. (2019), "Practical guidance on the use of sacubitril/valsartan for heart failure", Heart Fail Rev, 24(2), pp. 167-176.
8. Shah K. S., Xu H., et al. (2017), "Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes", J Am Coll Cardiol, 70(20), pp. 2476-2486.
9. Wang C. C., Chang H. Y., et al. (2016), "TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management", Acta Cardiol Sin, 32(4), pp. 400-11.
10. Writing Committee, Maddox T. M., et al. (2021), "2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee", J Am Coll Cardiol, 77(6), pp. 772-810.